ArticleScientific reports2025
Synthesis, SAR, and in silico studies of new benzochromene derivatives as insecticidal agents against Culex pipiens L. larvae and adults.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Synthesis, anti-proliferative evaluation, DFT,RSC advances · 2026Article
- New benzochromene-based compounds as potential EGFR-TK inhibitors: synthesis, anti-proliferative activity, molecular docking studies, and ADME profiles.RSC advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mosquito control is a favorable strategy to prevent mosquito-borne diseases. There are various approaches for the management of potentially dreadful mosquito populations such as larvicides and adulticides. In this study, a series of novel benzochromene derivatives were synthesized and evaluated for their insecticidal efficacy against larvae and adult stages of Culex pipiens L. The synthesized compounds underwent comprehensive structural characterization and toxicological evaluation, revealing their larvicidal and adulticidal activity for several derivatives. The tested compounds were more effective against larvae than adults of C. pipiens. Compounds 10 and 5 exhibited pronounced larvicidal activity, surpassing the reference compound temephos, with LC₅₀ values of 40.15 and 46.17 ppm, respectively. In addition, both compounds displayed remarkable adulticidal efficacy, with LC₅₀ values of 55.02 and 65.43 ppm, respectively, whereas compound 6 showed the lowest potency among the tested series with LC₅₀ value of 215.40 ppm. Notably, compounds 10 and 5 were 5.36- and 4.66-fold more active against larvae than compound 6, and demonstrated 5.28- and 4.44-fold higher adulticidal efficiency compared with deltamethrin. In cytotoxicity assays, compound 5 displayed an IC₅₀ value of 72.65 µM, while compound 10 showed an IC₅₀ of 90.32 µM, indicating low toxicity toward normal human cells and a favorable selectivity index. Molecular docking supported this observation by demonstrating strong and specific binding interactions with Anopheles gambiae acetylcholinesterase (AChE). Additionally, the DFT results provided insights into the electronic properties and stability of the compounds, while MEP mapping highlighted key reactive sites associated with target interactions. Structure-activity relationship (SAR) studies identified crucial functional groups influencing insecticidal potency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.